(Q34915865)

5 August 2017

Human intestinal microbiota and type 1 diabetes (English)

1 reference

5 August 2017

0 references

Outi Vaarala

1

1 reference

PubMed ID

23934614

5 August 2017

language of work or name

1 reference

1 October 2013

1 reference

5 August 2017

Current diabetes report

1 reference

5 August 2017

13

1 reference

5 August 2017

601-607

1 reference

5 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-013-0409-5

5 August 2017

0 references

cites work

The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Leaking gut in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

In vitro-deranged intestinal immune response to gliadin in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Toward defining the autoimmune microbiome for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Fecal microbiota composition differs between children with β-cell autoimmunity and those without

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Induction of colonic regulatory T cells by indigenous Clostridium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

The induction of Treg cells by gut-indigenous Clostridium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Dietary intervention in infancy and later signs of beta-cell autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Type 1 diabetes is associated with enterovirus infection in gut mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Prevention of virus-induced type 1 diabetes with antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Bacteriotherapy: the time has come

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-013-0409-5

Increased intestinal permeability precedes clinical onset of type 1 diabetes

21 January 2018

1 reference

12 December 2020

Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?

1 reference

12 December 2020

Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes

1 reference

12 December 2020

Does the intestinal bifidobacterial colonisation affect bacterial translocation?

1 reference

12 December 2020

Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes

1 reference

12 December 2020

10.1007/S11892-013-0409-5

Identifiers

DOI

1 reference

PubMed ID

23934614

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

23934614